TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Jan 30, 2026
2 min read
11

Tetragon Financial Group Ltd announced its diluted Net Asset Value (NAV) per share stood at $41.88 as of December 31, 2025. This reflects a marginal 0.1% increase for the month, while the investment company achieved a strong NAV total return of 19.6% for the full year.
The stable year-end NAV resulted from several offsetting movements within the portfolio. The company experienced write-downs on its LCM and Ripple holdings. However, these were counterbalanced by a small write-up to Equitix and continued strong performance from Hawke’s Point Fund 1, driven by its mining positions.
Gains from an undisclosed public U.S. equity, which is among the top ten holdings, also contributed positively. Notably, the Tetragon Life Science Fund entered the top ten holdings for the first time. This inclusion likely stems from robust performance in the biotech sector during December.
While the monthly NAV change was minimal, Tetragon's portfolio saw significant internal rebalancing. Strong gains in specific funds and equities offset valuation decreases in other areas, culminating in a successful annual return of 19.6%. Future performance will depend on the continued success of its key holdings in mining and life sciences.
Q: What was Tetragon's NAV total return for 2025?
A: Tetragon Financial Group reported a NAV total return of 19.6% for the full year 2025.
Q: Which holdings influenced the year-end NAV?
A: The NAV was affected by write-downs in LCM and Ripple, offset by a write-up in Equitix and strong performance from Hawke’s Point Fund 1 and an undisclosed U.S. public equity.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles